World's Best Scientists 2026 revealed!
Yves Vanrenterghem

Yves Vanrenterghem

D-Index & Metrics

Medicine

D-Index
96
Citations
31564
World Ranking
9735
National Ranking
110

Yves Vanrenterghem publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yves Vanrenterghem sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 546 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yves Vanrenterghem D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yves Vanrenterghem sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yves Vanrenterghem was affiliated with KU Leuven in Belgium. Their academic career involved contributions to research fields connected to this institution.

There are no recorded recent papers, co-authors, or frequent publication venues attributed to Yves Vanrenterghem in the source data provided.

Information regarding main fields of study, subfields, and specific research topics related to Yves Vanrenterghem is not available.

The source data does not include details about book publications or awards received by Yves Vanrenterghem.

Yves Vanrenterghem is deceased.

Best Publications

  • Reduced exposure to calcineurin inhibitors in renal transplantation.

    Henrik Ekberg;Helio Tedesco-Silva;Alper Demirbas;Štefan Vítko

  • PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

    J Grinyo;C Groth;R Pichlmayr;Sa Sadek

  • A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

    F. Vincenti;B. Charpentier;Y. Vanrenterghem;L. Rostaing

  • A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

    T van Gelder;L B Hilbrands;Yves Vanrenterghem;W Weimar

  • Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients

    Bert Bammens;Pieter Evenepoel;H Keuleers;Kristin Verbeke

  • The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

    Michael D. Hale;Andrew J. Nicholls;Roy E.S. Bullingham;Ronald Hené

  • Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.

    Sabina De Geest;Liesbeth Borgermans;Hilde Gemoets;Ivo Abraham;Ivo Abraham

  • Prevalence and management of anemia in renal transplant recipients: a European survey

    Yves Vanrenterghem;Claudio Ponticelli;José Maria Morales;Daniel Abramowicz

  • Free p-cresol is associated with cardiovascular disease in hemodialysis patients

    B.K.I. Meijers;B. Bammens;B. De Moor;K. Verbeke

  • Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

    Barry D. Kahan;Bruce A. Julian;Mark D. Pescovitz;Yves Vanrenterghem

  • Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study

    Pieter Evenepoel;Kathleen Claes;Dirk Kuypers;Bart Maes

  • Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation

    Henrik Ekberg;C Bernasconi;H Tedesco-Silva;S Vítko

  • p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease

    Björn K.I. Meijers;Kathleen Claes;Bert Bammens;Henriette de Loor

  • p -Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin

    Björn K. I. Meijers;Vicky De Preter;Kristin Verbeke;Yves Vanrenterghem

  • Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients

    G. Opelz;Y. Vanrenterghem;G. Kirste;D. W.r. Gray

  • Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study

    Henrik Ekberg;J Grinyó;B Nashan;Y Vanrenterghem

  • Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

    Bart D. Maes;Raymond Oyen;Kathleen Claes;Pieter Evenepoel

  • Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients.

    Y. Vanrenterghem;L. Roels;T. Lerut;J. Gruwez

  • Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

    J. O. Medina Pestana;J. M. Grinyo;Y. Vanrenterghem;T. Becker

  • FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

    Helio Tedesco-Silva;Georges Mourad;Barry D Kahan;Josep Grinyo Boira

Frequent Co-Authors

Dirk Kuypers
Dirk Kuypers KU Leuven
Kathleen Claes
Kathleen Claes Ghent University Hospital
Flavio Vincenti
Flavio Vincenti University of California, San Francisco
Sabina De Geest
Sabina De Geest University of Basel
Josep M. Grinyó
Josep M. Grinyó University of Barcelona
Christian P. Larsen
Christian P. Larsen Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but considering options beyond traditional medical school, there are several flexible paths available through online degrees. Many aspiring professionals start with nurse practitioner programs, which prepare you for advanced clinical roles through curricula designed for working adults.

One major concern for students is cost. Understanding how much is online nursing school can help you plan your finances and select a program that fits your budget. From entry-level to advanced degrees, financial accessibility is a top priority.

For nurses seeking teaching or research careers, doctorate in nursing education online programs offer the flexibility to reach the highest levels of academic achievement. For registered nurses wanting career advancement without excessive debt, exploring the cheapest rn to bsn online programs allows you to earn a bachelor’s degree while continuing to work.

With online learning, students can personalize their education, balance work-life commitments, and open new pathways into rewarding healthcare professions.

Best Scientists Citing Yves Vanrenterghem